Swiss Consensus Statement: Recommendations for optimising re-treatment with MabThera® (rituximab) in rheumatoid arthritis
Rituximab is an effective treatment of rheumatoid arthritis (RA), which has been approved for the treatment of moderate to severe disease in patients with an inadequate response to anti-TNF therapies. Rituximab differs from other available biological agents for RA by way of its unique mode of acti...
| 出版年: | Swiss Medical Weekly |
|---|---|
| 主要な著者: | A Finckh, D Kyburz, B Möller, U Schmiedel, P Villiger, U Walker |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2010-07-01
|
| 主題: | |
| オンライン･アクセス: | https://www.smw.ch/index.php/smw/article/view/1150 |
類似資料
Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche Ltd., Switzerland)
著者:: A. S. Avdeeva, 等
出版事項: (2019-03-01)
著者:: A. S. Avdeeva, 等
出版事項: (2019-03-01)
A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial
著者:: Gholamreza Toogeh, 等
出版事項: (2018-04-01)
著者:: Gholamreza Toogeh, 等
出版事項: (2018-04-01)
Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera in low-tumor-burden follicular lymphoma: the FLINTER study
著者:: Narendra Maharaj, 等
出版事項: (2025-05-01)
著者:: Narendra Maharaj, 等
出版事項: (2025-05-01)
THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY)
著者:: E. L. Nasonov, 等
出版事項: (2016-12-01)
著者:: E. L. Nasonov, 等
出版事項: (2016-12-01)
Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)
著者:: Alice Monteiro, 等
出版事項: (2018-06-01)
著者:: Alice Monteiro, 等
出版事項: (2018-06-01)
Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India
著者:: Keerthi Talari, 等
出版事項: (2021-01-01)
著者:: Keerthi Talari, 等
出版事項: (2021-01-01)
The Study of Teratogenic and Histological effects of treatment with Methotrexate and Rituximab in Swiss White Mice
著者:: Wajdi Sabeh Sadek, 等
出版事項: (2023-02-01)
著者:: Wajdi Sabeh Sadek, 等
出版事項: (2023-02-01)
The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis
著者:: L. P. Ananyeva, 等
出版事項: (2023-08-01)
著者:: L. P. Ananyeva, 等
出版事項: (2023-08-01)
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
著者:: Anna Vasilyevna Torgashina, 等
出版事項: (2010-08-01)
著者:: Anna Vasilyevna Torgashina, 等
出版事項: (2010-08-01)
EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
著者:: Mikhail Sergeyevich Protopopov, 等
出版事項: (2013-02-01)
著者:: Mikhail Sergeyevich Protopopov, 等
出版事項: (2013-02-01)
Safety and tolerability of rituximab in the treatment of systemic sclerosis
著者:: L. A. Garzanova, 等
出版事項: (2023-04-01)
著者:: L. A. Garzanova, 等
出版事項: (2023-04-01)
Use of rituximab in systemic lupus erythematosus in children: a review
著者:: A. N. Arefyeva
出版事項: (2019-11-01)
著者:: A. N. Arefyeva
出版事項: (2019-11-01)
Rituximab in Autoimmune CNS Disease
著者:: J Gordon Millichap, 等
出版事項: (2014-08-01)
著者:: J Gordon Millichap, 等
出版事項: (2014-08-01)
Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
著者:: Hussein A. Nasir, 等
出版事項: (2014-01-01)
著者:: Hussein A. Nasir, 等
出版事項: (2014-01-01)
The Use of Rituximab in Glomerulonephritis: What Is the Evidence?
著者:: Wenjuan Zhu, 等
出版事項: (2025-09-01)
著者:: Wenjuan Zhu, 等
出版事項: (2025-09-01)
Rituximab in Kidney-Limited Microscopic Polyangiitis
著者:: Anvitha Madhavaram, 等
出版事項: (2023-12-01)
著者:: Anvitha Madhavaram, 等
出版事項: (2023-12-01)
Acquired angioedema and rituximab-induced acute thrombocytopenia in splenic marginal zone lymphoma
著者:: Odd Terje Brustugun, 等
出版事項: (2025-07-01)
著者:: Odd Terje Brustugun, 等
出版事項: (2025-07-01)
Acquired Hemophilia A successfully treated with rituximab
著者:: Giovanni D'Arena, 等
出版事項: (2015-02-01)
著者:: Giovanni D'Arena, 等
出版事項: (2015-02-01)
Rituximab-induced serum sickness: Not so uncommon
著者:: Vikramraj K Jain
出版事項: (2018-01-01)
著者:: Vikramraj K Jain
出版事項: (2018-01-01)
Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy
著者:: A. S. Avdeeva, 等
出版事項: (2021-09-01)
著者:: A. S. Avdeeva, 等
出版事項: (2021-09-01)
Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
著者:: Paolo Cravedi, 等
出版事項: (2024-11-01)
著者:: Paolo Cravedi, 等
出版事項: (2024-11-01)
EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
著者:: E. I. Alexeeva, 等
出版事項: (2012-05-01)
著者:: E. I. Alexeeva, 等
出版事項: (2012-05-01)
Effectiveness of rituximab in nephrotic syndrome treatment
著者:: Katarzyna Popko, 等
出版事項: (2017-10-01)
著者:: Katarzyna Popko, 等
出版事項: (2017-10-01)
An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date
著者:: Yilmaz U, 等
出版事項: (2021-09-01)
著者:: Yilmaz U, 等
出版事項: (2021-09-01)
Effectiveness of rituximab in the treatment of patients with pemphigus vulgarus
著者:: Arfenya E. Karamova, 等
出版事項: (2024-11-01)
著者:: Arfenya E. Karamova, 等
出版事項: (2024-11-01)
Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
著者:: Tülay Şimşek, 等
出版事項: (2017-01-01)
著者:: Tülay Şimşek, 等
出版事項: (2017-01-01)
Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus
著者:: Didem Atay, 等
出版事項: (2012-03-01)
著者:: Didem Atay, 等
出版事項: (2012-03-01)
The Incidence of Electrocardiogram Changes Following Rituximab Infusion in Rheumatic Patients
著者:: Faraneh Farsad, 等
出版事項: (2025-03-01)
著者:: Faraneh Farsad, 等
出版事項: (2025-03-01)
Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49)
著者:: Nazanin Razazian
出版事項: (2023-01-01)
著者:: Nazanin Razazian
出版事項: (2023-01-01)
Rituximab induced lung injury
著者:: Rohit Chari, 等
出版事項: (2025-07-01)
著者:: Rohit Chari, 等
出版事項: (2025-07-01)
Effect of rituximab on heart involvement in systemic sclerosis
著者:: L. A. Garzanova, 等
出版事項: (2019-01-01)
著者:: L. A. Garzanova, 等
出版事項: (2019-01-01)
Correlation of the Complement Decay Accelerating Factor, Tumour Necrosis Factors-alpha, and Interleukin-1 Beta with the Response to Rituximab in Rheumatoid Arthritis Patients
著者:: Haidar Mohammed Hussein, 等
出版事項: (2025-02-01)
著者:: Haidar Mohammed Hussein, 等
出版事項: (2025-02-01)
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies
著者:: Stefano Stano, 等
出版事項: (2025-04-01)
著者:: Stefano Stano, 等
出版事項: (2025-04-01)
Rituximab como tratamiento de pénfigo refractario en pacientes mexicanos
著者:: Samantha Cruz-Meza, 等
出版事項: (2021-06-01)
著者:: Samantha Cruz-Meza, 等
出版事項: (2021-06-01)
Pénfigo vulgar grave: reporte de caso de tratamiento exitoso con plasmaféresis y rituximab
著者:: Claudia Marcela Gaviria, 等
出版事項: (2019-08-01)
著者:: Claudia Marcela Gaviria, 等
出版事項: (2019-08-01)
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
著者:: Marco Allinovi, 等
出版事項: (2025-08-01)
著者:: Marco Allinovi, 等
出版事項: (2025-08-01)
The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis
著者:: Šekib Sokolović, 等
出版事項: (2010-05-01)
著者:: Šekib Sokolović, 等
出版事項: (2010-05-01)
Severe headache in primary Sjögren’s syndrome responded to rituximab
著者:: Maysoun Kudsi, 等
出版事項: (2023-09-01)
著者:: Maysoun Kudsi, 等
出版事項: (2023-09-01)
Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia
著者:: Wu Yang, 等
出版事項: (2024-02-01)
著者:: Wu Yang, 等
出版事項: (2024-02-01)
Treatment Satisfaction and Health-Related Quality of Life in Iraqi Patients with Rheumatoid Arthritis Receiving Biologic Therapy; Rituximab
著者:: Aya Fawzi Talib, 等
出版事項: (2025-02-01)
著者:: Aya Fawzi Talib, 等
出版事項: (2025-02-01)
類似資料
-
Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche Ltd., Switzerland)
著者:: A. S. Avdeeva, 等
出版事項: (2019-03-01) -
A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial
著者:: Gholamreza Toogeh, 等
出版事項: (2018-04-01) -
Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera in low-tumor-burden follicular lymphoma: the FLINTER study
著者:: Narendra Maharaj, 等
出版事項: (2025-05-01) -
THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY)
著者:: E. L. Nasonov, 等
出版事項: (2016-12-01) -
Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)
著者:: Alice Monteiro, 等
出版事項: (2018-06-01)